Skip to main content
Premium Trial:

Request an Annual Quote

Jeffrey Buchalter

Inivata has appointed Jeffrey Buchalter as a non-executive director and chairman of the board. Most recently, Buchalter served as chief executive officer of Archimedes Pharma. He has received the Joseph F. Buckley Memorial Award from the American Cancer Society for commitment to cancer control and involvement in the oncology pharmaceutical field. Previously, Buchalter has been a collaborating partner in the President's national dialogue on cancer and acted as chairman of the board of directors to the National Childhood Cancer Foundation in the United States. 

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.